COL5A3 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-COL5A3 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | COL5A3 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.03 mL, 0.1 mL, 0.2 mL |
| Concentration | 1 mg/ml |
| Applications | Western Blot (WB), Immunohistochemistry (IHC) Paraffin, Immunofluorescence (IF), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: COL5A3 Polyclonal Antibody detects endogenous levels of COL5A3 protein. COL5A3 encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in COL5A3 are thought to be responsible for the symptoms of a subset of patients with Ehlers-Danlos syndrome type |
| Immunogen | Immunogen: Synthesized peptide derived from the N-terminal region of human COL5A3 at AA range: 190-270 |
| Other Names | [Rabbit COL5A3; COL5A3; Collagen alpha-3(V) chain] |
| Gene, Accession # | [COL5A3], Gene ID: 50509, NCBI: NP_056534.2, UniProt: P25940 |
| Catalog # | MBS9701746 |
| Price | $130, $220, $325 |
| Order / More Info | COL5A3 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies